Solis Partners installs solar power at Bristol-Myers Squibb

Share

Solis Partners, a leading commercial solar energy provider, has completed the installation of a roof-mounted solar PV system for Bristol-Myers Squibb, a premier biopharmaceutical company based in New York City that discovers, develops and delivers innovative medicines for treating serious diseases and is a recognized leader in environmental stewardship.

The 777.14 kW system has 3,172 panels across the whole 106,500 sq ft parking structure at the company's campus in Hopewell Township, New Jersey.

"It was really rewarding to partner with Bristol-Myers Squibb on this solar installation that will be owned and operated under a full service power purchase agreement," said Jamie Hahn, co-founder and managing director of Solis Partners.

"Reducing the company's environmental footprint with on-site solar power generation provides a cost-effective path to sustainability. Bristol-Myers is once again demonstrating its commitment to environmental leadership."

In the first year of operation, the system is expected to produce approximately 965,000 kWh of clean energy to the Bristol-Myers Squibb campus.